艾伯维Abbvie Inc (ABBV) 2012年年度报告「NYSE」.pdf

1、1 North Waukegan Road,North Chicago,IL 60064 U.S.A.1.847.932.7900 2012 annual report on form 10-k2013 notice of annual meeting and proxy statementSTOCKHOLDER INFORMATIONAbbVie Inc.Corporate Headquarters1 North Waukegan RoadNorth Chicago,IL Investor RelationsDept.ZZ05,APStockholder ServicesDept.312,A

2、P6DCorporate SecretaryDept,V364,AP34Stock ListingThe ticker for AbbVies common stock is ABBV.The principal market for AbbVie common stock is the NYSE.AbbVie common stock is also listed on the Chicago Stock Exchange,the NYSE Euronext Paris,and the SIX Swiss Exchange.Annual MeetingThe Annual Meeting w

3、ill be held on Monday,May 6,2013,at 9 a.m.at the Beechwood Hotel,363 Plantation Street,Worcester,MA 01605.Dividend Reinvestment PlanThe AbbVie Dividend Reinvestment Plan offers registered stockholders an opportunity to purchase additional shares,commission-free,through automatic dividend reinvestmen

4、t and/or optional cash investments.Interested persons may contact the transfer agent.Transfer AgentComputershare250 Royall StreetCanton,MA ABOUT ABBVIEAbbVie is a global,research-based biopharmaceutical company formed in 2013 following separation from Abbott.With its 125-year history,the companys mi

5、ssion is to use its expertise,dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the worlds most complex and serious diseases.In 2013,AbbVie employs approximately 21,500 people worldwide and markets medicines in more than 170 countries.Fo

6、r further information on the company and its people,portfolio and commitments,please visit Follow abbvie on Twitter or view careers on our Facebook or LinkedIn page.13NOV2012213657664DEC201212233206Dear AbbVie Stockholder:On January 1,2013,AbbVie was launched as an independent,$18 billion dollar bio